Further understanding the contributions of the cross talk among the signaling pathways governed by EGFR, c-ABL, β-catenin, and HOTAIR is expected to shed new light to the diagnosis, treatment, and prognosis of breast cancer. Here, ABL1 is linked to breast cancer.